Abstract
A 52-year-old, Caucasian male, workman, presented to the outpatient clinic for clinical assessment of uncontrolled hypertension. By about 10 years, he refers elevated blood pressure values, treated with a fix combination therapy based on beta-blocker (atenolol 100 mg) and diuretic (chlorthalidone 25 mg). 5 years ago, because of excessive bradycardia, atenolol and chlorthalidone were down-stepped to 50/12.5 mg/day. A Ca-antagonist (amlodipine, 10 mg) was added, with satisfactory home and office blood pressure control. By about 1 year, as a consequence of lower limbs oedema, his general practitioner reduced the dose of amlodipine to 5 mg/day and started therapy with doxazosin 2 mg/day. Since that period, the lower limb oedema, although still present, was ameliorated, but home and clinic blood pressure values were uncontrolled (around 150/95 mmHg).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.
Romero R, Bonet J, de la Sierra A, Aguilera MT. Undiagnosed obesity in hypertension: clinical and therapeutic implications. Blood Press. 2007;16:347–53.
Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84.
Jordan J, Yumuk V, Schlaich M, Nilsson PM, Zahorska-Markiewicz B, Grassi G, et al. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens. 2012;30:1047–55.
Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (Co-operation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30:633–46.
Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50:417–23.
Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung. 2007;185:67–72.
Kasiakogias A, Tsoufis C, Thomopoulos C, Aragiannis D, Alchanatis M, Tousoulis D, et al. Effects of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up. J Hypertens. 2013;31:352–60.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Virdis, A. (2016). Clinical Case 7: Patient with Severe Obesity. In: Hypertension and Comorbidities. Practical Case Studies in Hypertension Management. Springer, Cham. https://doi.org/10.1007/978-3-319-39164-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-39164-9_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39163-2
Online ISBN: 978-3-319-39164-9
eBook Packages: MedicineMedicine (R0)